NanoVax Therapeutics
PrivateCompany Overview
NanoVax Therapeutics operates in Healthcare & Life Sciences and is based in Amherst, Massachusetts. It was founded in 2025.
NanoVax Therapeutics is a biotechnology company developing next-generation nanoparticle-based cancer vaccines designed to prime and direct tumor-specific T-cell responses.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NanoVax Therapeutics Comparables
Compare NanoVax Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Foxcroft Therapeutics, Inc. | 91% | |
| Hopewell Therapeutics | 79% | |
| Bristol Myers Squibb | 74% |
For institutional investors. Book with your work email.
NanoVax Therapeutics Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NanoVax Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NanoVax Therapeutics's valuation, stock price, and market status.
Is NanoVax Therapeutics a public or private company?
NanoVax Therapeutics is a private company.
What is the current stock price of NanoVax Therapeutics?
NanoVax Therapeutics is a private company, so its shares have no public market price. Caplight tracks NanoVax Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NanoVax Therapeutics worth (valuation)?
Valuation information for NanoVax Therapeutics is not publicly available.
Can I buy NanoVax Therapeutics stock?
NanoVax Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NanoVax Therapeutics's last funding round?
Funding round information for NanoVax Therapeutics is not publicly available.
Who are the main investors in NanoVax Therapeutics?
Investor information for NanoVax Therapeutics is not publicly disclosed.
Will NanoVax Therapeutics IPO soon?
No public IPO plans have been announced for NanoVax Therapeutics.
How can I track NanoVax Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in NanoVax Therapeutics's shares on secondary markets.